This symposium review article features evidence, key learnings, and updates presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain. Taking place on 6th September 2022, this article details the key information shared at the symposium, including the spectrum of inflammatory pathways and heterogeneity of chronic obstructive pulmonary disease (COPD), current and emerging phenotypes/endotypes, and unmet needs in the standard-of-care management of patients with COPD.
Latest articles
All articles
12 Mins
12th
December
Clinical Applications of Hyperpolarised Xenon-129 MRI
The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive imaging technique…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
10 Mins
12th
December
IL-5 in Type 2 Inflammatory Diseases
Type 2 inflammation is involved in severe asthma (SA), chronic rhinosinusitis with nasal polyps (CRSwNP), and eosinophilic granulomatosis…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
6 Mins
22nd
October
Precision Strikes: Personalising Stage IIIA Lung Cancer Treatment with Targeted and Immune Therapies
The treatment landscape for potentially surgically resectable Stage IIIA non-small cell lung cancer (NSCLC), particularly for…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.